Call Us Today:
949.200.1600

Adnexal Carcinoma

Home > Diagnosis > Squamous Cell Carcinoma > Adnexal Carcinoma

Treatment for Microcystic Adnexal Carcinoma

ABOUT ADNEXAL CARCINOMA

In general, adenocarcinomas of skin, when diagnosed, must be differentiated from metastasis of a visceral adenocarcinoma to the skin. PET scan plays an important role in that setting. The most common adenocarcinoma of the skin is the cutaneous adnexal eccrine (sweat gland) carcinoma. Within the category of adnexal eccrine carcinomas, the most common include microcystic adnexal carcinoma (MAC), eccrine porocarcinoma, and hidradenocarcinoma. Less common subtypes are eccrine mucinous carcinoma, malignant eccrine spiradenoma, malignant mixed tumor, malignant cylindroma, and digital papillary eccrine adenoma.

 

Eccrine (sweat gland) porocarcinoma has a metastatic potential and a significant recurrence rate. MAC (microcystic adnexal carcinoma) is a locally aggressive tumor tending to have a wider subclinical spread than its obvious benign appearing surface lesion. Because of this silent spread, Mohs micrographic surgery often uncovers an extensive spread not appreciated prior to surgery. The good news is that it only has a rare metastatic potential, although it still carries a higher local recurrence rate than most other skin cancers.

 

Histologic grade of an adenocarcinoma is the most important factor in predicting its behavior. Higher grade tumors require combination therapy – primarily surgery and radiation. Surgery can be either wide local resection or Mohs micrographic surgery. Chemotherapy is an adjunct in the setting of bulky or unresectable disease.

Related Articles

Multiple Cutaneous Carcinomas in Organ Transplant Recipients
HISTORY  A 73-year-old kidney transplant recipient presented with multiple carcinomas including SCC, SCC in situ, and BCC of the face and scalp. DISCUSSION Organ transplant recipients can suffer from multiple cutaneous carcinomas. Some lesions can have a high risk of metastases, but most occur in multitudes in areas of extensive sun exposure. At SCARS Center,…
Read More
Desmoplastic / Spindle Cell Melanoma of the Scalp
A 67-year-old man with CLL presents with 3 month h/o 3 cm dense dermal growing scalp mass. Incisional biopsy showed spindle cell melanoma. The tumor was resected with a 2 cm margin. Final pathology showed malignant melanoma—spindle cell / desmoplastic type. Additional 1.2 cm margin was resected for wide clearance creating a 10 x 9…
Read More
Evaluation of Longitudinal Melanonychia
HISTORY An 84-year-old woman with a history of melanoma of the left upper back presents with an 11 month h/o left great toe discoloration. Biopsy of left great toe was performed on 08/05/2019. Previous h/o discoloration of the right fifth toe was biopsied and was negative for malignancy. DISCUSSION What is the cause of melanonychia…
Read More
Intralesional 5-fluorouracil for Cutaneous BCC and SCC
HISTORY  An 86-year-old man on hemodialysis with multiple medical problems and on warfarin presented with two carcinomas of the nasal tip: BCC of the left nasal tip and SCC of the right nasal tip. The ulceration of the right SCC exposed the alar cartilage. Patient completed six (6) 5-fluorouracil injections over a 5-week period. Complete…
Read More
Nasal Open Wound Complication
HISTORY A 73-year-old man with BCC of the nasal tip presented 1 week following Mohs excision. His reconstruction was delayed for an additional week for a cardiac work up. Nasal reconstruction was performed with a superior extended nasal myocutaneous flap (SENMI flap) and nasal septal cartilage grafts. The patient developed nasal tip incisional discharge 1…
Read More
Sentinel Lymph Node Biopsy for Cutaneous SCC
HISTORY A 58-year-old kidney transplant recipient presented with a 6-month history of squamous cell carcinoma of the left scalp. This large lesion was adjacent to the scar of a previous carcinoma excision in 2014. Patient is on sirolimus for his kidney transplant performed in 1984. He has had multiple BCCs and SCCs of scalp, back,…
Read More

STAY UP TO DATE

Receive research updates, inspiring stories, healthy living tips and more.

Something went wrong. Please check your entries and try again.

FOLLOW US

ELEVATING THE STANDARDS OF SKIN CANCER MANAGEMENT.

© 2018 SCARS Management Services. All rights reserved.